Emergent BioSolutions
EBS
#8035
Rank
ยฃ0.27 B
Marketcap
ยฃ5.36
Share price
-0.55%
Change (1 day)
26.41%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): ยฃ44.31 Million

According to Emergent BioSolutions 's latest financial reports the company's current earnings are ยฃ0.64 Billion. In 2025 the company made an earning of ยฃ0.10 Billion, an increase over its 2024 earnings that were of -ยฃ53.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ44.31 M-57.95%
2025 ยฃ0.10 B-297.64%
2024 -ยฃ53.34 Million-88.82%
2023 -ยฃ0.48 Billion242.73%
2022 -ยฃ0.14 Billion-153.8%
2021 ยฃ0.25 B-20.43%
2020 ยฃ0.32 B278.02%
2019 ยฃ86.04 M27.11%
2018 ยฃ67.68 M-27.12%
2017 ยฃ92.88 M17.21%
2016 ยฃ79.24 M0.45%
2015 ยฃ78.89 M73.51%
2014 ยฃ45.46 M41.36%
2013 ยฃ32.16 M35.2%
2012 ยฃ23.79 M0.4%
2011 ยฃ23.69 M-56.46%
2010 ยฃ54.42 M76.73%
2009 ยฃ30.79 M32.94%
2008 ยฃ23.16 M-5.62%
2007 ยฃ24.54 M
2005 ยฃ35.53 M269.89%
2004 ยฃ9.6 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.85 B 17,820.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.75 B 22,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ7.42 B 16,839.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-ยฃ8.69 Million-119.80%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
ยฃ15.3 M-65.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.23 Billion-622.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.68 B 3,742.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel